Indiana 2024 Regular Session

Indiana House Bill HB1182 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
	1	+	EH1182.2
	2	+	Reprinted
	3	+	February 20, 2024
	4	+	ENGROSSED
	5	+	HOUSE BILL No. 1182
	6	+	_____
	7	+	DIGEST OF HB 1182 (Updated February 19, 2024 2:44 pm - DI 106)
	8	+	Citations Affected: IC 4-22; IC 25-26; IC 35-48.
	9	+	Synopsis: Regulation of controlled substances. Relocates requirements
	10	+	that the board of pharmacy must comply with when adopting interim
	11	+	rules declaring a substance a synthetic drug from the professional
	12	+	licensing law to the statutes governing administrative rulemaking.
	13	+	Makes certain changes to the lists of controlled substances.
	14	+	Effective: Upon passage; July 1, 2024.
	15	+	McNamara, Steuerwald
	16	+	(SENATE SPONSOR — GLICK)
	17	+	January 9, 2024, read first time and referred to Committee on Courts and Criminal Code.
	18	+	January 18, 2024, reported — Do Pass.
	19	+	January 22, 2024, read second time, ordered engrossed. Engrossed.
	20	+	January 23, 2024, read third time, passed. Yeas 95, nays 0.
	21	+	SENATE ACTION
	22	+	February 5, 2024, read first time and referred to Committee on Corrections and Criminal
	23	+	Law.
	24	+	February 15, 2024, amended, reported favorably — Do Pass.
	25	+	February 19, 2024, read second time, amended, ordered engrossed.
	26	+	EH 1182—LS 6758/DI 92 Reprinted
	27	+	February 20, 2024
1	28		Second Regular Session of the 123rd General Assembly (2024)
2	29		PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
3	30		Constitution) is being amended, the text of the existing provision will appear in this style type,
4	31		additions will appear in this style type, and deletions will appear in this style type.
5	32		Additions: Whenever a new statutory provision is being enacted (or a new constitutional
6	33		provision adopted), the text of the new provision will appear in this style type. Also, the
7	34		word NEW will appear in that style type in the introductory clause of each SECTION that adds
8	35		a new provision to the Indiana Code or the Indiana Constitution.
9	36		Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
10	37		between statutes enacted by the 2023 Regular Session of the General Assembly.
11		-	HOUSE ENROLLED ACT No. 1182
12		-	AN ACT to amend the Indiana Code concerning criminal law and
13		-	procedure.
	38	+	ENGROSSED
	39	+	HOUSE BILL No. 1182
	40	+	A BILL FOR AN ACT to amend the Indiana Code concerning
	41	+	criminal law and procedure.
14	42		Be it enacted by the General Assembly of the State of Indiana:
15		-	SECTION 1. IC 4-22-2.3-8, AS ADDED BY P.L.249-2023,
16		-	SECTION 43, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
17		-	UPON PASSAGE]: Sec. 8. (a) The Indiana board of pharmacy, on its
18		-	own initiative or under a written request from the state police
19		-	department, the United States Drug Enforcement Administration,
20		-	or a poison control center, may adopt interim rules under
21		-	IC 4-22-2-37.2 to declare a substance is a synthetic drug if the board
22		-	finds that the substance:
23		-	(1) has been scheduled or emergency scheduled by the United
24		-	States Drug Enforcement Administration;
25		-	(2) has been scheduled, emergency scheduled, or criminalized by
26		-	another state; or
27		-	(3) has:
28		-	(A) a high potential for abuse; and
29		-	(B) no accepted medical use in treatment in the United States
30		-	or lacks accepted safety for use in treatment under medical
31		-	supervision.
32		-	(b) In making a determination under subsection (a)(3), the Indiana
33		-	board of pharmacy shall consider the following factors described in
34		-	IC 25-26-13-4.1. relating to the substance:
35		-	(1) The actual or relative potential for abuse.
36		-	HEA 1182 — Concur 2
37		-	(2) Scientific evidence of the substance's pharmacological
38		-	effect, if known.
39		-	(3) The state of scientific knowledge regarding the substance.
40		-	(4) The history and current pattern of abuse of the substance.
41		-	(5) The scope, duration, and significance of abuse of the
42		-	substance.
43		-	(6) The degree of risk to the public health.
44		-	(7) The psychic or psychological dependence liability of the
45		-	substance.
46		-	(c) Notwithstanding IC 4-22-2-37.2(i), a rule described in this
47		-	section becomes effective when the rule is published in the Indiana
48		-	Register. A rule described in this section expires not later than one (1)
49		-	year after June 30 of the year following the year in which the rule is
50		-	accepted for filing by the publisher of the Indiana Register and may not
51		-	be continued in another interim rule.
52		-	SECTION 2. IC 25-26-13-4.1, AS AMENDED BY P.L.196-2013,
53		-	SECTION 11, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
54		-	UPON PASSAGE]: Sec. 4.1. (a) The board may adopt an emergency
55		-	interim rule to declare that a substance is a synthetic drug in
56		-	accordance with the requirements of IC 4-22-2.3-8.
57		-	(b) The board may, on its own initiative or under a written request
58		-	from the state police department, the United States Drug Enforcement
59		-	Administration, or a poison control center, adopt an emergency rule
60		-	declaring a substance to be a synthetic drug if the board finds that the
61		-	substance:
62		-	(1) has been scheduled or emergency scheduled by the United
63		-	States Drug Enforcement Administration;
64		-	(2) has been scheduled, emergency scheduled, or criminalized by
65		-	another state; or
66		-	(3) has:
67		-	(A) a high potential for abuse; and
68		-	(B) no accepted medical use in treatment in the United States
69		-	or lacks accepted safety for use in treatment under medical
70		-	supervision.
71		-	(c) In making its determination under subsection (b)(3), the board
72		-	shall consider the following factors relating to the substance:
73		-	(1) The actual or relative potential for abuse.
74		-	(2) Scientific evidence of the substance's pharmacological effect,
75		-	if known.
76		-	(3) The state of current scientific knowledge regarding the
77		-	substance.
78		-	(4) The history and current pattern of abuse of the substance.
79		-	HEA 1182 — Concur 3
80		-	(5) The scope, duration, and significance of abuse of the
81		-	substance.
82		-	(6) The degree of risk to the public health.
83		-	(7) The psychic or psychological dependence liability of the
84		-	substance.
85		-	(d) A rule adopted under this section becomes effective thirty (30)
86		-	days after it is filed with the publisher under IC 4-22-2-37.1.
87		-	(e) A rule adopted under this section expires on June 30 of the year
88		-	following the year in which it is filed with the publisher under
89		-	IC 4-22-2-37.1.
90		-	(f) The board may readopt under this section an emergency rule that
91		-	has expired.
92		-	SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.48-2023,
93		-	SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
94		-	JULY 1, 2024]: Sec. 4. (a) The controlled substances listed in this
95		-	section are included in schedule I.
96		-	(b) Opiates. Any of the following opiates, including their isomers,
97		-	esters, ethers, salts, and salts of isomers, esters, and ethers, unless
98		-	specifically excepted by rule of the board or unless listed in another
99		-	schedule, whenever the existence of these isomers, esters, ethers, and
100		-	salts is possible within the specific chemical designation:
101		-	4-fluoroisobutyryl fentanyl
102		-	Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
103		-	piperidinyl]-N-phenylacetamide) (9815)
104		-	Acetyl fentanyl (Other names include:
105		-	N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
106		-	Acetylmethadol (9601)
107		-	Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
108		-	N-phenylacrylamide
109		-	Allylprodine (9602)
110		-	Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
111		-	thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
112		-	Alphacetylmethadol (9603)
113		-	Alphameprodine (9604)
114		-	Alphamethadol (9605)
115		-	Alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-
116		-	phenethylpiperidin- 4-yl)-N-phenylbutanamide) (9864)
117		-	Alphamethylfentanyl (9814)
118		-	Benzethidine (9606)
119		-	Beta-hydroxy-3-methylfentanyl (9831). Other name:
120		-	N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
121		-	]-N-phenylpropanamide
122		-	HEA 1182 — Concur 4
123		-	Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
124		-	phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
125		-	Betacetylmethadol (9607)
126		-	Betameprodine (9608)
127		-	Betamethadol (9609)
128		-	Betaprodine (9611)
129		-	Brorphine(9098). Other name:
130		-	1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2
131		-	H-benzo[d]imidazol-2-one
132		-	2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-dieth
133		-	ylethan-1-amine (butonitazene); other name: butoxynitazene
134		-	Clonitazene (9612)
135		-	Cyclopentyl fentanyl. Other name:
136		-	N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
137		-	Dextromoramide (9613)
138		-	Diampromide (9615)
139		-	Diethylthiambutene (9616)
140		-	N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-1-y
141		-	l)ethan-1-amine (flunitazene)
142		-	N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)eth
143		-	an-1-amine (metodesnitazene)
144		-	N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-
145		-	1-yl)ethan-1-amine (metonitazene)
146		-	N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-
147		-	1-yl)ethan-1-amine (protonitazene); other name: pronitazene
148		-	Difenoxin (9168)
149		-	Dimenoxadol (9617)
150		-	Dimepheptanol (9618)
151		-	2',5'-Dimethoxyfentanyl (N-(1- (2,5-dimethoxyphenethyl)
152		-	piperidin-4-yl)- N-phenylpropionamide) (9861)
153		-	Dimethylthiambutene (9619)
154		-	Dioxaphetyl butyrate (9621)
155		-	Dipipanone (9622)
156		-	2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethylethan-
157		-	1-amine (etodesnitazene; etazene)
158		-	2-(4-ethnoxybenzyl)5-nitro-1(2-(pyrorolidin-1-yl)ethyl)-1H-ben
159		-	zimidazol (N-pyrrolidino etonizatene; etonitazepyne)
160		-	Ethylmethylthiambutene (9623)
161		-	Etonitazene (9624)
162		-	Etoxeridine (9625)
163		-	Fentanyl related substances.
164		-	Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
165		-	HEA 1182 — Concur 5
166		-	N-phenylfuran- 2-carboxamide) (9834)
	43	+	1 SECTION 1. IC 4-22-2.3-8, AS ADDED BY P.L.249-2023,
	44	+	2 SECTION 43, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
	45	+	3 UPON PASSAGE]: Sec. 8. (a) The Indiana board of pharmacy, on its
	46	+	4 own initiative or under a written request from the state police
	47	+	5 department, the United States Drug Enforcement Administration,
	48	+	6 or a poison control center, may adopt interim rules under
	49	+	7 IC 4-22-2-37.2 to declare a substance is a synthetic drug if the board
	50	+	8 finds that the substance:
	51	+	9 (1) has been scheduled or emergency scheduled by the United
	52	+	10 States Drug Enforcement Administration;
	53	+	11 (2) has been scheduled, emergency scheduled, or criminalized by
	54	+	12 another state; or
	55	+	13 (3) has:
	56	+	14 (A) a high potential for abuse; and
	57	+	15 (B) no accepted medical use in treatment in the United States
	58	+	16 or lacks accepted safety for use in treatment under medical
	59	+	17 supervision.
	60	+	EH 1182—LS 6758/DI 92 2
	61	+	1 (b) In making a determination under subsection (a)(3), the Indiana
	62	+	2 board of pharmacy shall consider the following factors described in
	63	+	3 IC 25-26-13-4.1. relating to the substance:
	64	+	4 (1) The actual or relative potential for abuse.
	65	+	5 (2) Scientific evidence of the substance's pharmacological
	66	+	6 effect, if known.
	67	+	7 (3) The state of scientific knowledge regarding the substance.
	68	+	8 (4) The history and current pattern of abuse of the substance.
	69	+	9 (5) The scope, duration, and significance of abuse of the
	70	+	10 substance.
	71	+	11 (6) The degree of risk to the public health.
	72	+	12 (7) The psychic or psychological dependence liability of the
	73	+	13 substance.
	74	+	14 (c) Notwithstanding IC 4-22-2-37.2(i), a rule described in this
	75	+	15 section becomes effective when the rule is published in the Indiana
	76	+	16 Register. A rule described in this section expires not later than one (1)
	77	+	17 year after June 30 of the year following the year in which the rule is
	78	+	18 accepted for filing by the publisher of the Indiana Register and may not
	79	+	19 be continued in another interim rule.
	80	+	20 SECTION 2. IC 25-26-13-4.1, AS AMENDED BY P.L.196-2013,
	81	+	21 SECTION 11, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
	82	+	22 UPON PASSAGE]: Sec. 4.1. (a) The board may adopt an emergency
	83	+	23 interim rule to declare that a substance is a synthetic drug in
	84	+	24 accordance with the requirements of IC 4-22-2.3-8.
	85	+	25 (b) The board may, on its own initiative or under a written request
	86	+	26 from the state police department, the United States Drug Enforcement
	87	+	27 Administration, or a poison control center, adopt an emergency rule
	88	+	28 declaring a substance to be a synthetic drug if the board finds that the
	89	+	29 substance:
	90	+	30 (1) has been scheduled or emergency scheduled by the United
	91	+	31 States Drug Enforcement Administration;
	92	+	32 (2) has been scheduled, emergency scheduled, or criminalized by
	93	+	33 another state; or
	94	+	34 (3) has:
	95	+	35 (A) a high potential for abuse; and
	96	+	36 (B) no accepted medical use in treatment in the United States
	97	+	37 or lacks accepted safety for use in treatment under medical
	98	+	38 supervision.
	99	+	39 (c) In making its determination under subsection (b)(3), the board
	100	+	40 shall consider the following factors relating to the substance:
	101	+	41 (1) The actual or relative potential for abuse.
	102	+	42 (2) Scientific evidence of the substance's pharmacological effect,
	103	+	EH 1182—LS 6758/DI 92 3
	104	+	1 if known.
	105	+	2 (3) The state of current scientific knowledge regarding the
	106	+	3 substance.
	107	+	4 (4) The history and current pattern of abuse of the substance.
	108	+	5 (5) The scope, duration, and significance of abuse of the
	109	+	6 substance.
	110	+	7 (6) The degree of risk to the public health.
	111	+	8 (7) The psychic or psychological dependence liability of the
	112	+	9 substance.
	113	+	10 (d) A rule adopted under this section becomes effective thirty (30)
	114	+	11 days after it is filed with the publisher under IC 4-22-2-37.1.
	115	+	12 (e) A rule adopted under this section expires on June 30 of the year
	116	+	13 following the year in which it is filed with the publisher under
	117	+	14 IC 4-22-2-37.1.
	118	+	15 (f) The board may readopt under this section an emergency rule that
	119	+	16 has expired.
	120	+	17 SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.48-2023,
	121	+	18 SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
	122	+	19 JULY 1, 2024]: Sec. 4. (a) The controlled substances listed in this
	123	+	20 section are included in schedule I.
	124	+	21 (b) Opiates. Any of the following opiates, including their isomers,
	125	+	22 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
	126	+	23 specifically excepted by rule of the board or unless listed in another
	127	+	24 schedule, whenever the existence of these isomers, esters, ethers, and
	128	+	25 salts is possible within the specific chemical designation:
	129	+	26 4-fluoroisobutyryl fentanyl
	130	+	27 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
	131	+	28 piperidinyl]-N-phenylacetamide) (9815)
	132	+	29 Acetyl fentanyl (Other names include:
	133	+	30 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
	134	+	31 Acetylmethadol (9601)
	135	+	32 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
	136	+	33 N-phenylacrylamide
	137	+	34 Allylprodine (9602)
	138	+	35 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
	139	+	36 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
	140	+	37 Alphacetylmethadol (9603)
	141	+	38 Alphameprodine (9604)
	142	+	39 Alphamethadol (9605)
	143	+	40 Alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-
	144	+	41 phenethylpiperidin- 4-yl)-N-phenylbutanamide) (9864)
	145	+	42 Alphamethylfentanyl (9814)
	146	+	EH 1182—LS 6758/DI 92 4
	147	+	1 Benzethidine (9606)
	148	+	2 Beta-hydroxy-3-methylfentanyl (9831). Other name:
	149	+	3 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
	150	+	4 ]-N-phenylpropanamide
	151	+	5 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
	152	+	6 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
	153	+	7 Betacetylmethadol (9607)
	154	+	8 Betameprodine (9608)
	155	+	9 Betamethadol (9609)
	156	+	10 Betaprodine (9611)
	157	+	11 Brorphine(9098). Other name:
	158	+	12 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2
	159	+	13 H-benzo[d]imidazol-2-one
	160	+	14 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-dieth
	161	+	15 ylethan-1-amine (butonitazene); other name: butoxynitazene
	162	+	16 Clonitazene (9612)
	163	+	17 Cyclopentyl fentanyl. Other name:
	164	+	18 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
	165	+	19 Dextromoramide (9613)
	166	+	20 Diampromide (9615)
	167	+	21 Diethylthiambutene (9616)
	168	+	22 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-1-y
	169	+	23 l)ethan-1-amine (flunitazene)
	170	+	24 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)eth
	171	+	25 an-1-amine (metodesnitazene)
	172	+	26 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-
	173	+	27 1-yl)ethan-1-amine (metonitazene)
	174	+	28 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-
	175	+	29 1-yl)ethan-1-amine (protonitazene); other name: pronitazene
	176	+	30 Difenoxin (9168)
	177	+	31 Dimenoxadol (9617)
	178	+	32 Dimepheptanol (9618)
	179	+	33 2',5'-Dimethoxyfentanyl (N-(1- (2,5-dimethoxyphenethyl)
	180	+	34 piperidin-4-yl)- N-phenylpropionamide) (9861)
	181	+	35 Dimethylthiambutene (9619)
	182	+	36 Dioxaphetyl butyrate (9621)
	183	+	37 Dipipanone (9622)
	184	+	38 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethylethan-
	185	+	39 1-amine (etodesnitazene; etazene)
	186	+	40 2-(4-ethnoxybenzyl)5-nitro-1(2-(pyrorolidin-1-yl)ethyl)-1H-ben
	187	+	41 zimidazol (N-pyrrolidino etonizatene; etonitazepyne)
	188	+	42 Ethylmethylthiambutene (9623)
	189	+	EH 1182—LS 6758/DI 92 5
	190	+	1 Etonitazene (9624)
	191	+	2 Etoxeridine (9625)
	192	+	3 Fentanyl related substances.
	193	+	4 Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
	194	+	5 N-phenylfuran- 2-carboxamide) (9834)
	195	+	6 3-Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
	196	+	7 N-phenylfuran- 3- carboxamide) (9860)
	197	+	8 Furethidine (9626)
	198	+	9 Hydroxypethidine (9627)
	199	+	10 Isobutyryl fentanyl. Other name:
	200	+	11 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
	201	+	12 Isotonitazene. Other name: N,N-diethyl-2-
	202	+	13 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
	203	+	14 1-yl)ethan-1-amine)
	204	+	15 Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)-
	205	+	16 N- phenylbutanamide) (9862)
	206	+	17 Ketobemidone (9628)
	207	+	18 Levomoramide (9629)
	208	+	19 Levophenacylmorphan (9631)
	209	+	20 Meta-Fluorofentanyl (N-(3- fluorophenyl)- N-
	210	+	21 (1-phenethylpiperidin-4-yl) propionamide) (9857)
	211	+	22 Meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)- N-
	212	+	23 (1-phenethylpiperidin-4-yl) isobutyramide) (9858)
	213	+	24 Methoxyacetyl fentanyl. Other name:
	214	+	25 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
	215	+	26 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
	216	+	27 piperidyl]-N-phenyl-propanimide](9813)
	217	+	28 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
	218	+	29 piperidinyl]-N-phenylpropanamide) (9833)
	219	+	30 M etonitazene
	220	+	31 (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimida
	221	+	32 zol-1-yl)ethan-1-amine) (9757)
	222	+	33 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
	223	+	34 Morpheridine (9632)
	224	+	35 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
	225	+	36 including any isomers, salts, or salts of isomers (9818)
	226	+	37 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
	227	+	38 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
	228	+	39 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
	229	+	40 (beta-hydroxythiofentanyl)
	230	+	41 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
	231	+	42 (para-chloroisobutyryl fentanyl)
	232	+	EH 1182—LS 6758/DI 92 6
	233	+	1 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
	234	+	2 acetamide (ocfentanil)
	235	+	3 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
	236	+	4 (para-fluorobutyryl fentanyl)
	237	+	5 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
	238	+	6 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
	239	+	7 fentanyl)
	240	+	8 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
	241	+	9 fentanyl)
	242	+	10 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
	243	+	11 (para-methoxybutyryl fentanyl)
	244	+	12 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
	245	+	13 (thenylfentanyl), including any isomers, salts, or salts of isomers
	246	+	14 (9834)
	247	+	15 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
	248	+	16 fentanyl)
	249	+	17 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
	250	+	18 (cyclopentyl fentanyl)
	251	+	19 Noracymethadol (9633)
	252	+	20 Norlevorphanol (9634)
	253	+	21 Normethadone (9635)
	254	+	22 Norpipanone (9636)
	255	+	23 Ocfentanil. Other name:
	256	+	24 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
	257	+	25 acetamide
	258	+	26 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
	259	+	27 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
	260	+	28 Ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-
	261	+	29 (1-phenethylpiperidin-4-yl)furan-2-carboxamide) (9863)
	262	+	30 Para-chloroisobutyryl fentanyl. Other name:
	263	+	31 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
	264	+	32 Para-fluorobutyryl fentanyl. Other name:
	265	+	33 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
	266	+	34 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
	267	+	35 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
	268	+	36 Para-methoxybutyryl fentanyl. Other name:
	269	+	37 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
	270	+	38 Para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-
	271	+	39 (1-phenethylpiperidin-4-yl) furan-2-carboxamide (9859)
	272	+	40 Para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)- N-
	273	+	41 (1-phenethylpiperidin- 4-yl)cyclopropanecarboxamide) (9865)
	274	+	42 Phenadoxone (9637)
	275	+	EH 1182—LS 6758/DI 92 7
	276	+	1 Phenampromide (9638)
	277	+	2 Phenomorphan (9647)
	278	+	3 Phenoperidine (9641)
	279	+	4 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
	280	+	5 Piritramide (9642)
	281	+	6 Proheptazine (9643)
	282	+	7 Properidine (9644)
	283	+	8 Propiram (9649)
	284	+	9 Racemoramide (9645)
	285	+	10 Tetrahydrofuranyl fentanyl. Other name:
	286	+	11 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
	287	+	12 oxamide
	288	+	13 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
	289	+	14 piperidinyl]-propanamide) (9835)
	290	+	15 Tianeptine (7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c]
	291	+	16 [2,1]benzothiazepin-11-yl)amino]heptanoic acid)
	292	+	17 Tilidine (9750)
	293	+	18 Trimeperidine (9646)
	294	+	19 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
	295	+	20 N-methyl- benzamide)
	296	+	21 Valeryl fentanyl. Other name:
	297	+	22 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
	298	+	23 Zipeprol (1-methoxy-3- [4-(2-methoxy-2-phenylethyl) piperazin-
	299	+	24 1-yl]- 1- phenylpropan- 2-ol) (9873)
	300	+	25 (c) Opium derivatives. Any of the following opium derivatives, their
	301	+	26 salts, isomers, and salts of isomers, unless specifically excepted by rule
	302	+	27 of the board or unless listed in another schedule, whenever the
	303	+	28 existence of these salts, isomers, and salts of isomers is possible within
	304	+	29 the specific chemical designation:
	305	+	30 Acetorphine (9319)
	306	+	31 Acetyldihydrocodeine (9051)
	307	+	32 Benzylmorphine (9052)
	308	+	33 Codeine methylbromide (9070)
	309	+	34 Codeine-N-Oxide (9053)
	310	+	35 Cyprenorphine (9054)
	311	+	36 Desomorphine (9055)
	312	+	37 Dihydromorphine (9145)
	313	+	38 Drotebanol (9335)
	314	+	39 Etorphine (except hydrochloride salt) (9056)
	315	+	40 Heroin (9200)
	316	+	41 Hydromorphinol (9301)
	317	+	42 Methyldesorphine (9302)
	318	+	EH 1182—LS 6758/DI 92 8
	319	+	1 Methyldihydromorphine (9304)
	320	+	2 Morphine methylbromide (9305)
	321	+	3 Morphine methylsulfonate (9306)
	322	+	4 Morphine-N-Oxide (9307)
	323	+	5 Myrophine (9308)
	324	+	6 Nicocodeine (9309)
	325	+	7 Nicomorphine (9312)
	326	+	8 Normorphine (9313)
	327	+	9 Pholcodine (9314)
	328	+	10 Thebacon (9315)
	329	+	11 (d) Hallucinogenic substances. Unless specifically excepted or
	330	+	12 unless listed in another schedule, any material, compound, mixture, or
	331	+	13 preparation which contains any quantity of the following
	332	+	14 hallucinogenic, psychedelic, or psychogenic substances, their salts,
	333	+	15 isomers, and salts of isomers whenever the existence of these salts,
	334	+	16 isomers, and salts of isomers is possible within the specific chemical
	335	+	17 designation (for purposes of this subsection only, the term "isomer"
	336	+	18 includes the optical, position, and geometric isomers):
	337	+	19 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
	338	+	20 TCPy.
	339	+	21 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
	340	+	22 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
	341	+	23 4-Bromo-2, 5-DMA.
	342	+	24 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
	343	+	25 or other names:
	344	+	26 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
	345	+	27 alpha-desmethyl DOB; 2C-B, Nexus.
	346	+	28 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
	347	+	29 DOET.
	348	+	30 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
	349	+	31 Other name: 2C-T-7.
	350	+	32 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
	351	+	33 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
	352	+	34 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
	353	+	35 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
	354	+	36 PMA.
	355	+	37 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
	356	+	38 Name: MMDA.
	357	+	39 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
	358	+	40 isomers, salts, or salts of isomers (7439). Other name:
	359	+	41 5-MeO-DIPT.
	360	+	42 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
	361	+	EH 1182—LS 6758/DI 92 9
	362	+	1 and other names: 4-methyl-2,
	363	+	2 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
	364	+	3 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
	365	+	4 MDA.
	366	+	5 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
	367	+	6 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
	368	+	7 phenethylamine; N-ethyl MDA; MDE; and MDEA.
	369	+	8 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
	370	+	9 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
	371	+	10 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
	372	+	11 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
	373	+	12 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
	374	+	13 (16) Alpha-methyltryptamine (7432). Other name: AMT.
	375	+	14 (17) Bufotenine (7433). Some trade and other names:
	376	+	15 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
	377	+	16 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
	378	+	17 5-hydroxy-N, N-dimethyltryptamine; mappine.
	379	+	18 (18) Diethyltryptamine (7434). Some trade or other names: N,
	380	+	19 N-Diethyltryptamine; DET.
	381	+	20 (19) Dimethyltryptamine (7435). Some trade or other names:
	382	+	21 DMT.
	383	+	22 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
	384	+	23 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
	385	+	24 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
	386	+	25 (21) Lysergic acid diethylamide (7315). Other name: LSD.
	387	+	26 (22) Marijuana (7360).
	388	+	27 (23) Mescaline (7381).
	389	+	28 (24) Methoxetamine[2-(ethylamino)-2-(3-methoxyphenyl)
	390	+	29 cyclohexan-1-one or 2-(3-methoxyphenyl)-2-(ethylamino)-
	391	+	30 cyclohexanone].
	392	+	31 (25) Parahexyl (7374). Some trade or other names:
	393	+	32 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
	394	+	33 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
	395	+	34 (26) Peyote (7415), including:
	396	+	35 (A) all parts of the plant that are classified botanically as
	397	+	36 lophophora williamsii lemaire, whether growing or not;
	398	+	37 (B) the seeds thereof;
	399	+	38 (C) any extract from any part of the plant; and
	400	+	39 (D) every compound, manufacture, salt, derivative, mixture, or
	401	+	40 preparation of the plant, its seeds, or extracts.
	402	+	41 (27) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
	403	+	42 (28) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
	404	+	EH 1182—LS 6758/DI 92 10
	405	+	1 names: N-hydroxy-alpha-methyl-3,4
	406	+	2 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
	407	+	3 (29) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
	408	+	4 (30) Psilocybin (7437).
	409	+	5 (31) Psilocyn (7438).
	410	+	6 (32) Tetrahydrocannabinols (7370), including synthetic
	411	+	7 equivalents of the substances contained in the plant, or in the
	412	+	8 resinous extractives of Cannabis, sp. and synthetic substances,
	413	+	9 derivatives, and their isomers with similar chemical structure and
	414	+	10 pharmacological activity such as:
	415	+	11 (A) ð
	416	+	1
	417	+	cis or trans tetrahydrocannabinol, and their optical
	418	+	12 isomers;
	419	+	13 (B) ð
	420	+	6
	421	+	cis or trans tetrahydrocannabinol, and their optical
	422	+	14 isomers; and
	423	+	15 (C) ð
	424	+	3,
	425	+	4 cis or trans tetrahydrocannabinol, and their optical
	426	+	16 isomers.
	427	+	17 Since nomenclature of these substances is not internationally
	428	+	18 standardized, compounds of these structures, regardless of
	429	+	19 numerical designation of atomic positions are covered. Other
	430	+	20 name: THC.
	431	+	21 (33) Ethylamine analog of phencyclidine (7455). Some trade or
	432	+	22 other names: N-Ethyl-1-phenylcyclohexylamine;
	433	+	23 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
	434	+	24 ethylamine; cyclohexamine; PCE.
	435	+	25 (34) Pyrrolidine analog of phencyclidine (7458). Some trade or
	436	+	26 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
	437	+	y; PHP.
	438	+	27 (35) Thiophene analog of phencyclidine (7470). Some trade or
	439	+	28 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
	440	+	29 Analog of Phencyclidine; TPCP.
	441	+	30 (36) Salvia divinorum or salvinorin A, including:
	442	+	31 (A) all parts of the plant that are classified botanically as salvia
	443	+	32 divinorum, whether growing or not;
	444	+	33 (B) the seeds of the plant;
	445	+	34 (C) any extract from any part of the plant; and
	446	+	35 (D) every compound, manufacture, salt, derivative, mixture, or
	447	+	36 preparation of the plant, its seeds, or extracts.
	448	+	37 (37) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
	449	+	38 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
	450	+	39 5-MeO-DMT.
	451	+	40 (38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
	452	+	41 (39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
	453	+	42 (40) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
	454	+	EH 1182—LS 6758/DI 92 11
	455	+	1 (41) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
	456	+	2 (42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
	457	+	3 (43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
	458	+	4 (2C-T-4).
	459	+	5 (44) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
	460	+	6 (45) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
	461	+	7 (46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
	462	+	8 (47) Deschloroketamine (2-Phenyl-2-
	463	+	9 (methylamino)cyclohexanone).
	464	+	10 (48) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
	465	+	11 ethyltryptamine).
	466	+	12 (49) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
	467	+	13 (50) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
	468	+	14 (other names: eutylone; bk-EBDB (7549)).
	469	+	15 (51) N-(1-amino- 3,3-dimethyl-1- oxobutan-2-yl)-
	470	+	16 1-butyl-1H-indazole-3- carboxamide (other name:
	471	+	17 ADB–BUTINACA) (7027).
	472	+	18 (52) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other
	473	+	19 names: á-PiHP; alpha-PiHP) (7551).
	474	+	20 (53) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other
	475	+	21 names: 3–MMC; 3-methylmethcathinone) (1259).
	476	+	22 (e) Depressants. Unless specifically excepted in a rule adopted by
	477	+	23 the board or unless listed in another schedule, any material, compound,
	478	+	24 mixture, or preparation which contains any quantity of the following
	479	+	25 substances having a depressant effect on the central nervous system,
	480	+	26 including its salts, isomers, and salts of isomers whenever the existence
	481	+	27 of such salts, isomers, and salts of isomers is possible within the
	482	+	28 specific chemical designation:
	483	+	29 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
	484	+	30 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
	485	+	31 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
	486	+	32 Pasaden)
	487	+	33 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
	488	+	34 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
	489	+	35 Gamma-hydroxybutyric acid (other names include GHB;
	490	+	36 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
	491	+	37 oxybate; sodium oxybutyrate) (2010)
	492	+	38 Mecloqualone (2572)
	493	+	39 Methaqualone (2565)
	494	+	40 (f) Stimulants. Unless specifically excepted or unless listed in
	495	+	41 another schedule, any material, compound, mixture, or preparation that
	496	+	42 contains any quantity of the following substances having a stimulant
	497	+	EH 1182—LS 6758/DI 92 12
	498	+	1 effect on the central nervous system, including its salts, isomers, and
	499	+	2 salts of isomers:
	500	+	3 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
	501	+	4 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590).
	502	+	5 Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten- 5-
	503	+	6 yl)amino] heptanoic acid) (1219).
	504	+	7 Aminorex (1585). Other names: aminoxaphen;
	505	+	8 2-amino-5-phenyl-2-oxazoline; or
	506	+	9 4,5-dihydro-5-phenyl-2-oxazolamine.
	507	+	10 4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro- 4-methyl-5-(4-
	508	+	11 methylphenyl)- 2- oxazolamine; 4-methyl-5- (4-methylphenyl)-
	509	+	12 4,5-dihydro-1,3-oxazol- 2-amine).
	510	+	13 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
	511	+	14 -1-one. Synonyms: BMDP, N-benzyl methylone,
	512	+	15 3,4-Methylenedioxy-Nbenzylcathinone,
	513	+	16 N-benzyl-3,4-methylenedioxycathinone.
	514	+	17 Cathinone (1235). Some trade or other names:
	515	+	18 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
	516	+	19 2-aminopropiophenone; and norephedrone.
	517	+	20 Fenethylline (1503).
	518	+	21 N-Benzylpiperazine (7493). Other names: BZP; and
	519	+	22 1-benzylpiperazine.
	520	+	23 N-ethylamphetamine (1475).
	521	+	24 Mesocarb (N-phenyl-N-(3-(1-
	522	+	25 phenylpropan-2-yl)-1,2,3-oxadiazol-3- ium-5yl)carbamimidate)
	523	+	26 (1227).
	524	+	27 Methcathinone (1237). Some other trade names:
	525	+	28 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
	526	+	29 Monomethylpropion; UR 1431.
	527	+	30 N, N-dimethylamphetamine (1480). Other names: N,
	528	+	31 N-alpha-trimethyl-benzeneethanamine; and N,
	529	+	32 N-alpha-trimethylphenethylamine.
	530	+	33 Methiopropamine (N-methyl-1- (thiophen-2-yl) propan-2-
	531	+	34 amine) (methiopropamine). (1478).
	532	+	35 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
	533	+	36 SECTION 4. IC 35-48-2-6, AS AMENDED BY P.L.48-2023,
	534	+	37 SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
	535	+	38 JULY 1, 2024]: Sec. 6. (a) The controlled substances listed in this
	536	+	39 section are included in schedule II.
	537	+	40 (b) Any of the following substances, except those narcotic drugs
	538	+	41 listed in other schedules, whether produced directly or indirectly by
	539	+	42 extraction from substances of vegetable origin, or independently by
	540	+	EH 1182—LS 6758/DI 92 13
	541	+	1 means of chemical synthesis, or by combination of extraction and
	542	+	2 chemical synthesis:
	543	+	3 (1) Opium and opiate, and any salt, compound, derivative, or
	544	+	4 preparation of opium or opiate, excluding apomorphine,
	545	+	5 dextrorphan, nalbuphine, naloxone, naltrexone, and their
	546	+	6 respective salts but including:
	547	+	7 (A) raw opium (9600);
	548	+	8 (B) opium extracts (9610);
	549	+	9 (C) opium fluid extracts (9620);
	550	+	10 (D) powdered opium (9639);
	551	+	11 (E) granulated opium (9640);
	552	+	12 (F) tincture of opium (9630);
	553	+	13 (G) codeine (9050);
	554	+	14 (H) dihydroetorphine (9334);
	555	+	15 (I) ethylmorphine (9190);
	556	+	16 (J) etorphine hydrochloride (9059);
	557	+	17 (K) hydrocodone (9193), and any hydrocodone combination
	558	+	18 product, as determined by the federal Food and Drug
	559	+	19 Administration;
	560	+	20 (L) hydromorphone (9150);
	561	+	21 (M) metopon (9260);
	562	+	22 (N) morphine (9300);
	563	+	23 (O) oxycodone (9143);
	564	+	24 (P) oxymorphone (9652);
	565	+	25 (Q) thebaine (9333); and
	566	+	26 (R) oripavine.
	567	+	27 (2) Any salt, compound, isomer, derivative, or preparation thereof
	568	+	28 which is chemically equivalent or identical with any of the
	569	+	29 substances referred to in subdivision (b)(1) of this section, but not
	570	+	30 including the isoquinoline alkaloids of opium.
	571	+	31 (3) Opium poppy and poppy straw.
	572	+	32 (4) Cocaine (9041). Coca leaves (9040) and any salt,
	573	+	33 compound, derivative, or preparation of coca leaves
	574	+	34 (including cocaine (9041) and ecgonine (8180) and their salts,
	575	+	35 isomers, derivatives, and salts of isomers and derivatives), and
	576	+	36 any salt, compound, derivative, or preparation thereof that is
	577	+	37 chemically equivalent or identical with these substances
	578	+	38 except that the substances do not include:
	579	+	39 (A) decocainized coca leaves or an extraction of coca leaves
	580	+	40 that does not contain cocaine or ecgonine;
	581	+	41 (B) [
	582	+	123
	583	+	I]ioflupane; or
	584	+	42 (C) [
	585	+	18
	586	+	F]FP-CIT.
	587	+	EH 1182—LS 6758/DI 92 14
	588	+	1 (5) Concentrate of poppy straw (the crude extract of poppy straw
	589	+	2 in either liquid, solid, or powder form which contains the
	590	+	3 phenanthrene alkaloids of the opium poppy) (9670).
	591	+	4 (c) Opiates. Any of the following opiates, including their isomers,
	592	+	5 esters, ethers, salts, and salts of isomers, esters, and ethers whenever
	593	+	6 the existence of these isomers, esters, ethers, and salts is possible
	594	+	7 within the specific chemical designation:
	595	+	8 Alfentanil (9737)
	596	+	9 Alphaprodine (9010)
	597	+	10 Anileridine (9020)
	598	+	11 Bezitramide (9800)
	599	+	12 Bulk dextropropoxyphene (nondosage forms) (9273)
	600	+	13 Carfentanil (9743)
	601	+	14 Dihydrocodeine (9120)
	602	+	15 Diphenoxylate (9170)
	603	+	16 Fentanyl (9801)
	604	+	17 Isomethadone (9226)
	605	+	18 Levo-alphacetylmethadol (9648). Other names:
	606	+	19 Levo-alpha-acetylmethadol; levomethadyl acetate; and LAAM.
	607	+	20 Levomethorphan (9210)
	608	+	21 Levorphanol (9220)
	609	+	22 Metazocine (9240)
	610	+	23 Methadone (9250)
	611	+	24 Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4,
	612	+	25 4-diphenyl butane (9254)
	613	+	26 Moramide-Intermediate, 2-methyl-3-morpholino-1,
	614	+	27 1-diphenylpropane- carboxylic acid (9802)
	615	+	28 Oliceridine (N-[(3-methoxythiophen- 2-yl) methyl]({2- [(9R)-9-
	616	+	29 (pyridin- 2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) (9245)
	617	+	30 Pethidine (Meperidine) (9230)
	618	+	31 Pethidine-Intermediate- A, 4-cyano-1-methyl-4-phenylpiperidine
	619	+	32 (9232)
	620	+	33 Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
	621	+	34 (9233)
	622	+	35 Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carbo
	623	+	36 xylic acid (9234)
	624	+	37 Phenazocine (9715)
	625	+	38 Piminodine (9730)
	626	+	39 Racemethorphan (9732)
	627	+	40 Racemorphan (9733)
	628	+	41 Remifentanil (9739)
	629	+	42 Sufentanil (9740)
	630	+	EH 1182—LS 6758/DI 92 15
	631	+	1 Tapentadol
	632	+	2 Thiafentanil
	633	+	3 (d) Stimulants. Any material compound, mixture, or preparation
	634	+	4 which contains any quantity of the following substances having a
	635	+	5 potential for abuse associated with a stimulant effect on the central
	636	+	6 nervous system:
	637	+	7 (1) Amphetamine, its salts, optical isomers, and salts of its optical
	638	+	8 isomers (1100).
	639	+	9 (2) Methamphetamine, including its salts, isomers, and salts of its
	640	+	10 isomers (1105).
	641	+	11 (3) Phenmetrazine and its salts (1631).
	642	+	12 (4) Methylphenidate (1724).
	643	+	13 (5) Lisdexamfetamine, its salts, its isomers, and salts of its
	644	+	14 isomers.
	645	+	15 (e) Depressants. Unless specifically excepted by rule of the board
	646	+	16 or unless listed in another schedule, any material, compound, mixture,
	647	+	17 or preparation which contains any quantity of the following substances
	648	+	18 having a depressant effect on the central nervous system, including its
	649	+	19 salts, isomers, and salts of isomers whenever the existence of such
	650	+	20 salts, isomers, and salts of isomers is possible within the specific
	651	+	21 chemical designation:
	652	+	22 Amobarbital (2125)
	653	+	23 Glutethimide (2550)
	654	+	24 Pentobarbital (2270)
	655	+	25 Phencyclidine (7471)
	656	+	26 Secobarbital (2315)
	657	+	27 (f) Immediate precursors. Unless specifically excepted by rule of the
	658	+	28 board or unless listed in another schedule, any material, compound,
	659	+	29 mixture, or preparation which contains any quantity of the following
	660	+	30 substances:
	661	+	31 (1) Immediate precursor to amphetamine and methamphetamine:
	662	+	32 Phenylacetone (8501). Some trade or other names:
	663	+	33 phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
	664	+	34 ketone.
	665	+	35 (2) Immediate precursors to phencyclidine (PCP):
	666	+	36 (A) 1-phenylcyclohexylamine (7460); or
	667	+	37 (B) 1-piperidinocyclohexanecarbonitrile (PCC) (8603).
	668	+	38 (3) Immediate precursor to fentanyl:
	669	+	39 (A) 4-anilino-N-phenethylpiperidine (ANPP) (8333); or
	670	+	40 (B) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)
	671	+	41 (8366).
	672	+	42 (g) Hallucinogenic substances:
	673	+	EH 1182—LS 6758/DI 92 16
	674	+	1 Dronabinol oral solution. Other name:
	675	+	2 (-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC).
	676	+	3 Nabilone (7379). Other name: (+/-)-trans-3-
	677	+	4 (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy -6,
	678	+	5 6-dimethyl-9H-dibenzo [b,d] pyran-9-one.
	679	+	6 SECTION 5. IC 35-48-2-10, AS AMENDED BY P.L.48-2023,
	680	+	7 SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
	681	+	8 JULY 1, 2024]: Sec. 10. (a) The controlled substances listed in this
	682	+	9 section are included in schedule IV.
	683	+	10 (b) Narcotic drugs. Unless specifically excepted in a rule adopted
	684	+	11 by the board or unless listed in another schedule, any material,
	685	+	12 compound, mixture, or preparation containing any of the following
	686	+	13 narcotic drugs, or their salts calculated as the free anhydrous base or
	687	+	14 alkaloid, in the following limited quantities:
	688	+	15 (1) Not more than 1 milligram of difenoxin (9618) and not less
	689	+	16 than 25 micrograms of atropine sulfate per dosage unit.
	690	+	17 (2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
	691	+	18 diphenyl-3-methyl-2-propionoxybutane (9278).
	692	+	19 (c) Depressants. Unless specifically excepted in a rule adopted by
	693	+	20 the board or unless listed in another schedule, any material, compound,
	694	+	21 mixture, or preparation which contains any quantity of the following
	695	+	22 substances, including its salts, isomers, and salts of isomers whenever
	696	+	23 the existence of such salts, isomers, and salts of isomers is possible
	697	+	24 within the specific chemical designation:
	698	+	25 Alfaxalone (2731).
	699	+	26 Alprazolam (2882).
	700	+	27 Barbital (2145).
	701	+	28 Brexanolone (2400).
	702	+	29 Bromazepam (2748).
	703	+	30 Camazepam (2749).
	704	+	31 Carisoprodol.
	705	+	32 Chloral betaine (2460).
	706	+	33 Chloral hydrate (2465).
	707	+	34 Chlordiazepoxide (2744).
	708	+	35 Clobazam (2751).
	709	+	36 Clonazepam (2737).
	710	+	37 Clorazepate (2768).
	711	+	38 Clotiazepam (2752).
	712	+	39 Cloxazolam (2753).
	713	+	40 Daridorexant (2410).
	714	+	41 Delorazepam (2754).
	715	+	42 Diazepam (2765).
	716	+	EH 1182—LS 6758/DI 92 17
	717	+	1 Dichloralphenazone (2467).
	718	+	2 Estazolam (2756).
	719	+	3 Ethchlorvynol (2540).
	720	+	4 Ethinamate (2545).
	721	+	5 Ethyl loflazepate (2758).
	722	+	6 Fludiazepam (2759).
	723	+	7 Flunitrazepam (2763).
	724	+	8 Flurazepam (2767).
	725	+	9 Fospropofol (2138).
	726	+	10 Halazepam (2762).
	727	+	11 Haloxazolam (2771).
	728	+	12 Ketazolam (2772).
	729	+	13 Lemborexant (2245).
	730	+	14 Loprazolam (2773).
	731	+	15 Lorazepam (2885).
	732	+	16 Lormetazepam (2774).
	733	+	17 Mebutamate (2800).
	734	+	18 Medazepam (2836).
	735	+	19 Meprobamate (2820).
	736	+	20 Methohexital (2264).
	737	+	21 Methylphenobarbital (mephobarbital) (2250).
	738	+	22 Midazolam (2884).
	739	+	23 Nimetazepam (2837).
	740	+	24 Nitrazepam (2834).
	741	+	25 Nordiazepam (2838).
	742	+	26 Oxazepam (2835).
	743	+	27 Oxazolam (2839).
	744	+	28 Paraldehyde (2585).
	745	+	29 Petrichloral (2591).
	746	+	30 Phenobarbital (2285).
	747	+	31 Pinazepam (2883).
	748	+	32 Prazepam (2764).
	749	+	33 Quazepam (2881).
	750	+	34 Remimazolam (2846).
	751	+	35 Suvorexant (2223).
	752	+	36 Temazepam (2925).
	753	+	37 Tetrazepam (2886).
	754	+	38 Triazolam (2887).
	755	+	39 Zaleplon (2781).
	756	+	40 Zolpidem (Ambien) (2783).
	757	+	41 Zopiclone (2784).
	758	+	42 Zuranolone (2420).
	759	+	EH 1182—LS 6758/DI 92 18
	760	+	1 (d) Fenfluramine. Any material, compound, mixture, or preparation
	761	+	2 which contains any quantity of the following substances, including its
	762	+	3 salts, isomers (whether optical, position, or geometric), and salts of
	763	+	4 such isomers, whenever the existence of such salts, isomers, and salts
	764	+	5 of isomers is possible.
	765	+	6 Fenfluramine (1670).
	766	+	7 (e) (d) Stimulants. Unless specifically excepted in a rule adopted by
	767	+	8 the board or unless listed in another schedule, any material, compound,
	768	+	9 mixture, or preparation which contains any quantity of the following
	769	+	10 substances having a stimulant effect on the central nervous system,
	770	+	11 including its salts, isomers (whether optical, position, or geometric),
	771	+	12 and salts of such isomers whenever the existence of such salts, isomers,
	772	+	13 and salts of isomers is possible within the specific chemical
	773	+	14 designation:
	774	+	15 Cathine ((+)-norpseudoephedrine) (1230).
	775	+	16 Diethylpropion (1610).
	776	+	17 Fencamfamin (1760).
	777	+	18 Fenproporex (1575).
	778	+	19 Mazindol (1605).
	779	+	20 Mefenorex (1580).
	780	+	21 Modafinil (1680).
	781	+	22 Pemoline (including organometallic complexes and chelates
	782	+	23 thereof) (1530).
	783	+	24 Phentermine (1640).
	784	+	25 Pipradrol (1750).
	785	+	26 Serdexmethylphenidate (1729).
	786	+	27 Sibutramine (1675).
	787	+	28 Solriamfetol (2-amino-3-phenylpropyl carbamate;
	788	+	29 benzenepropanol, beta-amino-, carbamate (ester)) (1650).
	789	+	30 SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
	790	+	31 (f) (e) Other substances. Unless specifically excepted or unless
	791	+	32 listed in another schedule, any material, compound, mixture, or
	792	+	33 preparation which contains any quantity of the following substances
	793	+	34 including its salts:
	794	+	35 Butorphanol (including its optical isomers) (9720).
	795	+	36 Pentazocine (9709).
	796	+	37 (g) (f) Tramadol (Ultram).
	797	+	38 (h) (g) The board may except by rule any compound, mixture, or
	798	+	39 preparation containing any depressant substance listed in subsection
	799	+	40 (b), (c), (d), or (e), or (f) from the application of any part of this article
	800	+	41 if the compound, mixture, or preparation contains one (1) or more
	801	+	42 active medicinal ingredients not having a depressant effect on the
	802	+	EH 1182—LS 6758/DI 92 19
	803	+	1 central nervous system, and if the admixtures are included therein in
	804	+	2 combinations, quantity, proportion, or concentration that vitiate the
	805	+	3 potential for abuse of the substances which have a depressant effect on
	806	+	4 the central nervous system.
	807	+	5 SECTION 6. An emergency is declared for this act.
	808	+	EH 1182—LS 6758/DI 92 20
	809	+	COMMITTEE REPORT
	810	+	Mr. Speaker: Your Committee on Courts and Criminal Code, to
	811	+	which was referred House Bill 1182, has had the same under
	812	+	consideration and begs leave to report the same back to the House with
	813	+	the recommendation that said bill do pass.
	814	+	(Reference is to HB 1182 as introduced.)
	815	+	MCNAMARA
	816	+	Committee Vote: Yeas 12, Nays 0
	817	+	_____
	818	+	COMMITTEE REPORT
	819	+	Madam President: The Senate Committee on Corrections and
	820	+	Criminal Law, to which was referred House Bill No. 1182, has had the
	821	+	same under consideration and begs leave to report the same back to the
	822	+	Senate with the recommendation that said bill be AMENDED as
	823	+	follows:
	824	+	Page 3, between lines 16 and 17, begin a new paragraph and insert:
	825	+	"SECTION 3. IC 25-26-13-31.2, AS AMENDED BY P.L.56-2023,
	826	+	SECTION 239, IS AMENDED TO READ AS FOLLOWS
	827	+	[EFFECTIVE JULY 1, 2024]: Sec. 31.2. (a) A pharmacist may
	828	+	administer an immunization to an individual under a drug order or
	829	+	prescription.
	830	+	(b) Subject to subsection (c), a pharmacist may administer
	831	+	immunizations for the following an immunization that is
	832	+	recommended by the federal Centers for Disease Control and
	833	+	Prevention Advisory Committee on Immunization Practices to a
	834	+	group of individuals under a drug order, under a prescription, or
	835	+	according to a protocol approved by a physician.
	836	+	(1) Influenza.
	837	+	(2) Shingles (herpes zoster).
	838	+	(3) Pneumonia.
	839	+	(4) Tetanus, diphtheria, and acellular pertussis (whooping cough).
	840	+	(5) Human papillomavirus (HPV) infection.
	841	+	(6) Meningitis.
	842	+	(7) Measles, mumps, and rubella.
	843	+	(8) Varicella.
	844	+	(9) Hepatitis A.
	845	+	(10) Hepatitis B.
	846	+	(11) Haemophilus influenzae type b (Hib).
	847	+	EH 1182—LS 6758/DI 92 21
	848	+	(12) Coronavirus disease.
	849	+	(c) A pharmacist may administer an immunization under subsection
	850	+	(b) if the following requirements are met:
	851	+	(1) The physician specifies in the drug order, prescription, or
	852	+	protocol the group of individuals to whom the immunization may
	853	+	be administered.
	854	+	(2) The physician who writes the drug order, prescription, or
	855	+	protocol is licensed and actively practicing with a medical office
	856	+	in Indiana and not employed by a pharmacy.
	857	+	(3) The pharmacist who administers the immunization is
	858	+	responsible for notifying, not later than fourteen (14) days after
	859	+	the pharmacist administers the immunization, the physician who
	860	+	authorized the immunization and the individual's primary care
	861	+	physician that the individual received the immunization.
	862	+	(4) If the physician uses a protocol, the protocol may apply only
	863	+	to an individual or group of individuals who
	864	+	(A) except as provided in clause (B), are at least eleven (11)
	865	+	years of age. or
	866	+	(B) for the pneumonia immunization under subsection (b)(3),
	867	+	are at least fifty (50) years of age.
	868	+	(5) Before administering an immunization to an individual
	869	+	according to a protocol approved by a physician, the pharmacist
	870	+	must receive the consent of one (1) of the following:
	871	+	(A) If the individual to whom the immunization is to be
	872	+	administered is at least eleven (11) years of age but less than
	873	+	eighteen (18) years of age, the parent or legal guardian of the
	874	+	individual.
	875	+	(B) If the individual to whom the immunization is to be
	876	+	administered is at least eighteen (18) years of age but has a
	877	+	legal guardian, the legal guardian of the individual.
	878	+	(C) If the individual to whom the immunization is to be
	879	+	administered is at least eighteen (18) years of age but has no
	880	+	legal guardian, the individual.
	881	+	A parent or legal guardian who is required to give consent under
	882	+	this subdivision must be present at the time of immunization.
	883	+	(d) If the Indiana department of health or the department of
	884	+	homeland security determines that an emergency exists, subject to
	885	+	IC 16-41-9-1.7(a)(2), a pharmacist may administer any immunization
	886	+	in accordance with:
	887	+	(1) the requirements of subsection (c)(1) through (c)(3); and
	888	+	(2) any instructions in the emergency determination.
	889	+	(e) A pharmacist or pharmacist's designee shall provide
	890	+	EH 1182—LS 6758/DI 92 22
	891	+	immunization data to the immunization data registry (IC 16-38-5) in a
	892	+	manner prescribed by the Indiana department of health unless:
	893	+	(1) the individual receiving the immunization;
	894	+	(2) the parent of the individual receiving the immunization, if the
	895	+	individual receiving the immunization is less than eighteen (18)
	896	+	years of age; or
	897	+	(3) the legal guardian of the individual receiving the
	898	+	immunization, if a legal guardian has been appointed;
	899	+	has completed and filed with the pharmacist or pharmacist's designee
	900	+	a written immunization data exemption form, as provided in
	901	+	IC 16-38-5-2.
	902	+	(f) If an immunization is administered under a protocol, then the
	903	+	name, license number, and contact information of the physician who
	904	+	wrote the protocol must be posted in the location where the
	905	+	immunization is administered. A copy of the protocol must be available
	906	+	for inspection by the individual receiving the immunization.
	907	+	(g) A pharmacist may administer an immunization that is provided
	908	+	according to a standing order, prescription, or protocol issued under
	909	+	this section or IC 16-19-4-11 by the state health commissioner or the
	910	+	commissioner's designated public health authority who is a licensed
	911	+	prescriber. If a pharmacist has received a protocol to administer an
	912	+	immunization from a physician and that specific immunization is
	913	+	covered by a standing order, prescription, or protocol issued by the
	914	+	state health commissioner or the commissioner's designated public
	915	+	health authority, the pharmacist must administer the immunization
	916	+	according to the standing order, prescription, or protocol issued by the
	917	+	state health commissioner or the commissioner's designated public
	918	+	health authority.".
	919	+	Page 3, between lines 39 and 40, begin a new line block indented
	920	+	and insert:
	921	+	''Alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-
	922	+	phenethylpiperidin- 4-yl)-N-phenylbutanamide) (9864)".
	923	+	Page 4, between lines 30 and 31, begin a new line block indented
	924	+	and insert:
	925	+	"2',5'-Dimethoxyfentanyl (N-(1- (2,5-dimethoxyphenethyl)
	926	+	piperidin-4-yl)- N-phenylpropionamide) (9861)".
	927	+	Page 4, line 42, delete "fentanyl." and insert ''fentanyl
	928	+	(N-(1-phenethylpiperidin- 4-yl)- N-phenylfuran- 2-carboxamide)
	929	+	(9834)
167	930		3-Furanyl fentanyl (N-(1-phenethylpiperidin- 4-yl)-
168		-	N-phenylfuran- 3- carboxamide) (9860)
169		-	Furethidine (9626)
170		-	Hydroxypethidine (9627)
171		-	Isobutyryl fentanyl. Other name:
172		-	N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
173		-	Isotonitazene. Other name: N,N-diethyl-2-
174		-	(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
175		-	1-yl)ethan-1-amine)
176		-	Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)-
177		-	N- phenylbutanamide) (9862)
178		-	Ketobemidone (9628)
179		-	Levomoramide (9629)
180		-	Levophenacylmorphan (9631)
181		-	Meta-Fluorofentanyl (N-(3- fluorophenyl)- N-
	931	+	N-phenylfuran- 3- carboxamide) (9860)".
	932	+	Page 5, between lines 7 and 8, begin a new line block indented and
	933	+	EH 1182—LS 6758/DI 92 23
	934	+	insert:
	935	+	"Isovaleryl fentanyl (3-methyl- N-(1-phenethylpiperidin-4-yl)-
	936	+	N- phenylbutanamide) (9862)".
	937	+	Page 5, between lines 10 and 11, begin a new line block indented
	938	+	and insert:
	939	+	''Meta-Fluorofentanyl (N-(3- fluorophenyl)- N-
182	940		(1-phenethylpiperidin-4-yl) propionamide) (9857)
183	941		Meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)- N-
184		-	(1-phenethylpiperidin-4-yl) isobutyramide) (9858)
185		-	Methoxyacetyl fentanyl. Other name:
186		-	2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
187		-	3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
188		-	piperidyl]-N-phenyl-propanimide](9813)
189		-	3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
190		-	piperidinyl]-N-phenylpropanamide) (9833)
191		-	M etonitazene
192		-	(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimida
193		-	zol-1-yl)ethan-1-amine) (9757)
194		-	MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
195		-	Morpheridine (9632)
196		-	N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
197		-	including any isomers, salts, or salts of isomers (9818)
198		-	N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
199		-	N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
200		-	(2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
201		-	(beta-hydroxythiofentanyl)
202		-	N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
203		-	(para-chloroisobutyryl fentanyl)
204		-	N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
205		-	acetamide (ocfentanil)
206		-	N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
207		-	(para-fluorobutyryl fentanyl)
208		-	HEA 1182 — Concur 6
209		-	N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
210		-	as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
211		-	fentanyl)
212		-	N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
213		-	fentanyl)
214		-	N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
215		-	(para-methoxybutyryl fentanyl)
216		-	N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
217		-	(thenylfentanyl), including any isomers, salts, or salts of isomers
218		-	(9834)
219		-	N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
220		-	fentanyl)
221		-	N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
222		-	(cyclopentyl fentanyl)
223		-	Noracymethadol (9633)
224		-	Norlevorphanol (9634)
225		-	Normethadone (9635)
226		-	Norpipanone (9636)
227		-	Ocfentanil. Other name:
228		-	N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
229		-	acetamide
230		-	Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
231		-	N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
232		-	Ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-
233		-	(1-phenethylpiperidin-4-yl)furan-2-carboxamide) (9863)
234		-	Para-chloroisobutyryl fentanyl. Other name:
235		-	N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
236		-	Para-fluorobutyryl fentanyl. Other name:
237		-	N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
238		-	Para-fluorofentanyl (N-(4-fluorophenyl)-N-
239		-	[1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
240		-	Para-methoxybutyryl fentanyl. Other name:
241		-	N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
242		-	Para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-
	942	+	(1-phenethylpiperidin-4-yl) isobutyramide) (9858)".
	943	+	Page 6, between lines 14 and 15, begin a new line block indented
	944	+	and insert:
	945	+	''Ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)- N-
	946	+	(1-phenethylpiperidin-4-yl)furan-2-carboxamide) (9863)".
	947	+	Page 6, between lines 22 and 23, begin a new line block indented
	948	+	and insert:
	949	+	''Para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)- N-
243	950		(1-phenethylpiperidin-4-yl) furan-2-carboxamide (9859)
244	951		Para-Methylcyclopropyl fentanyl (N-(4-methylphenyl)- N-
245		-	(1-phenethylpiperidin- 4-yl)cyclopropanecarboxamide) (9865)
246		-	Phenadoxone (9637)
247		-	Phenampromide (9638)
248		-	Phenomorphan (9647)
249		-	Phenoperidine (9641)
250		-	PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
251		-	HEA 1182 — Concur 7
252		-	Piritramide (9642)
253		-	Proheptazine (9643)
254		-	Properidine (9644)
255		-	Propiram (9649)
256		-	Racemoramide (9645)
257		-	Tetrahydrofuranyl fentanyl. Other name:
258		-	N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
259		-	oxamide
260		-	Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
261		-	piperidinyl]-propanamide) (9835)
262		-	Tianeptine (7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c]
263		-	[2,1]benzothiazepin-11-yl)amino]heptanoic acid)
264		-	Tilidine (9750)
265		-	Trimeperidine (9646)
266		-	U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
267		-	N-methyl- benzamide)
268		-	Valeryl fentanyl. Other name:
269		-	N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
270		-	Zipeprol (1-methoxy-3- [4-(2-methoxy-2-phenylethyl) piperazin-
271		-	1-yl]- 1- phenylpropan- 2-ol) (9873)
272		-	(c) Opium derivatives. Any of the following opium derivatives, their
273		-	salts, isomers, and salts of isomers, unless specifically excepted by rule
274		-	of the board or unless listed in another schedule, whenever the
275		-	existence of these salts, isomers, and salts of isomers is possible within
276		-	the specific chemical designation:
277		-	Acetorphine (9319)
278		-	Acetyldihydrocodeine (9051)
279		-	Benzylmorphine (9052)
280		-	Codeine methylbromide (9070)
281		-	Codeine-N-Oxide (9053)
282		-	Cyprenorphine (9054)
283		-	Desomorphine (9055)
284		-	Dihydromorphine (9145)
285		-	Drotebanol (9335)
286		-	Etorphine (except hydrochloride salt) (9056)
287		-	Heroin (9200)
288		-	Hydromorphinol (9301)
289		-	Methyldesorphine (9302)
290		-	Methyldihydromorphine (9304)
291		-	Morphine methylbromide (9305)
292		-	Morphine methylsulfonate (9306)
293		-	Morphine-N-Oxide (9307)
294		-	HEA 1182 — Concur 8
295		-	Myrophine (9308)
296		-	Nicocodeine (9309)
297		-	Nicomorphine (9312)
298		-	Normorphine (9313)
299		-	Pholcodine (9314)
300		-	Thebacon (9315)
301		-	(d) Hallucinogenic substances. Unless specifically excepted or
302		-	unless listed in another schedule, any material, compound, mixture, or
303		-	preparation which contains any quantity of the following
304		-	hallucinogenic, psychedelic, or psychogenic substances, their salts,
305		-	isomers, and salts of isomers whenever the existence of these salts,
306		-	isomers, and salts of isomers is possible within the specific chemical
307		-	designation (for purposes of this subsection only, the term "isomer"
308		-	includes the optical, position, and geometric isomers):
309		-	(1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
310		-	TCPy.
311		-	(2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
312		-	other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
313		-	4-Bromo-2, 5-DMA.
314		-	(3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
315		-	or other names:
316		-	2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
317		-	alpha-desmethyl DOB; 2C-B, Nexus.
318		-	(4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
319		-	DOET.
320		-	(5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
321		-	Other name: 2C-T-7.
322		-	(6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
323		-	names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
324		-	(7) 4-Methoxyamphetamine (7411). Some trade or other names:
325		-	4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
326		-	PMA.
327		-	(8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
328		-	Name: MMDA.
329		-	(9) 5-Methoxy-N, N-diisopropyltryptamine, including any
330		-	isomers, salts, or salts of isomers (7439). Other name:
331		-	5-MeO-DIPT.
332		-	(10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
333		-	and other names: 4-methyl-2,
334		-	5-dimethoxy-a-methylphenethylamine; DOM; and STP.
335		-	(11) 3, 4-methylenedioxy amphetamine (7400). Other name:
336		-	MDA.
337		-	HEA 1182 — Concur 9
338		-	(12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
339		-	names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
340		-	phenethylamine; N-ethyl MDA; MDE; and MDEA.
341		-	(13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
342		-	(14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
343		-	(15) Alpha-ethyltryptamine (7249). Some trade and other names:
344		-	Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
345		-	3-(2-aminobutyl) indole; [alpha]-ET; and AET.
346		-	(16) Alpha-methyltryptamine (7432). Other name: AMT.
347		-	(17) Bufotenine (7433). Some trade and other names:
348		-	3-(B-Dimethylaminoethyl)-5-hydroxyindole;
349		-	3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
350		-	5-hydroxy-N, N-dimethyltryptamine; mappine.
351		-	(18) Diethyltryptamine (7434). Some trade or other names: N,
352		-	N-Diethyltryptamine; DET.
353		-	(19) Dimethyltryptamine (7435). Some trade or other names:
354		-	DMT.
355		-	(20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
356		-	7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
357		-	(1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
358		-	(21) Lysergic acid diethylamide (7315). Other name: LSD.
359		-	(22) Marijuana (7360).
360		-	(23) Mescaline (7381).
361		-	(24) Methoxetamine[2-(ethylamino)-2-(3-methoxyphenyl)
362		-	cyclohexan-1-one or 2-(3-methoxyphenyl)-2-(ethylamino)-
363		-	cyclohexanone].
364		-	(25) Parahexyl (7374). Some trade or other names:
365		-	3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
366		-	9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
367		-	(26) Peyote (7415), including:
368		-	(A) all parts of the plant that are classified botanically as
369		-	lophophora williamsii lemaire, whether growing or not;
370		-	(B) the seeds thereof;
371		-	(C) any extract from any part of the plant; and
372		-	(D) every compound, manufacture, salt, derivative, mixture, or
373		-	preparation of the plant, its seeds, or extracts.
374		-	(27) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
375		-	(28) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
376		-	names: N-hydroxy-alpha-methyl-3,4
377		-	(methylenedioxy)phenethylamine; and N-hydroxy MDA.
378		-	(29) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
379		-	(30) Psilocybin (7437).
380		-	HEA 1182 — Concur 10
381		-	(31) Psilocyn (7438).
382		-	(32) Tetrahydrocannabinols (7370), including synthetic
383		-	equivalents of the substances contained in the plant, or in the
384		-	resinous extractives of Cannabis, sp. and synthetic substances,
385		-	derivatives, and their isomers with similar chemical structure and
386		-	pharmacological activity such as:
387		-	(A) ð
388		-	1
389		-	cis or trans tetrahydrocannabinol, and their optical
390		-	isomers;
391		-	(B) ð
392		-	6
393		-	cis or trans tetrahydrocannabinol, and their optical
394		-	isomers; and
395		-	(C) ð
396		-	3,
397		-	4 cis or trans tetrahydrocannabinol, and their optical
398		-	isomers.
399		-	Since nomenclature of these substances is not internationally
400		-	standardized, compounds of these structures, regardless of
401		-	numerical designation of atomic positions are covered. Other
402		-	name: THC.
403		-	(33) Ethylamine analog of phencyclidine (7455). Some trade or
404		-	other names: N-Ethyl-1-phenylcyclohexylamine;
405		-	(1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
406		-	ethylamine; cyclohexamine; PCE.
407		-	(34) Pyrrolidine analog of phencyclidine (7458). Some trade or
408		-	other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
409		-	y; PHP.
410		-	(35) Thiophene analog of phencyclidine (7470). Some trade or
411		-	other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
412		-	Analog of Phencyclidine; TPCP.
413		-	(36) Salvia divinorum or salvinorin A, including:
414		-	(A) all parts of the plant that are classified botanically as salvia
415		-	divinorum, whether growing or not;
416		-	(B) the seeds of the plant;
417		-	(C) any extract from any part of the plant; and
418		-	(D) every compound, manufacture, salt, derivative, mixture, or
419		-	preparation of the plant, its seeds, or extracts.
420		-	(37) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
421		-	names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
422		-	5-MeO-DMT.
423		-	(38) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
424		-	(39) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
425		-	(40) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
426		-	(41) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
427		-	(42) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
428		-	(43) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
429		-	(2C-T-4).
430		-	HEA 1182 — Concur 11
431		-	(44) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
432		-	(45) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
433		-	(46) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
434		-	(47) Deschloroketamine (2-Phenyl-2-
435		-	(methylamino)cyclohexanone).
436		-	(48) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
437		-	ethyltryptamine).
438		-	(49) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
439		-	(50) 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one
440		-	(other names: eutylone; bk-EBDB (7549)).
441		-	(51) N-(1-amino- 3,3-dimethyl-1- oxobutan-2-yl)-
	952	+	(1-phenethylpiperidin- 4-yl)cyclopropanecarboxamide)
	953	+	(9865)".
	954	+	Page 10, between lines 37 and 38, begin a new line block indented
	955	+	and insert:
	956	+	''(51) N-(1-amino- 3,3-dimethyl-1- oxobutan-2-yl)-
442	957		1-butyl-1H-indazole-3- carboxamide (other name:
443	958		ADB–BUTINACA) (7027).
444	959		(52) 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (other
445	960		names: á-PiHP; alpha-PiHP) (7551).
446	961		(53) 2-(methylamino)-1-(3-methylphenyl)propan-1-one (other
447		-	names: 3–MMC; 3-methylmethcathinone) (1259).
448		-	(e) Depressants. Unless specifically excepted in a rule adopted by
449		-	the board or unless listed in another schedule, any material, compound,
450		-	mixture, or preparation which contains any quantity of the following
451		-	substances having a depressant effect on the central nervous system,
452		-	including its salts, isomers, and salts of isomers whenever the existence
453		-	of such salts, isomers, and salts of isomers is possible within the
454		-	specific chemical designation:
455		-	Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
456		-	thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
457		-	include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
458		-	Pasaden)
459		-	Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
460		-	4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
461		-	Gamma-hydroxybutyric acid (other names include GHB;
462		-	gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
463		-	oxybate; sodium oxybutyrate) (2010)
464		-	Mecloqualone (2572)
465		-	Methaqualone (2565)
466		-	(f) Stimulants. Unless specifically excepted or unless listed in
467		-	another schedule, any material, compound, mixture, or preparation that
468		-	contains any quantity of the following substances having a stimulant
469		-	effect on the central nervous system, including its salts, isomers, and
470		-	salts of isomers:
471		-	([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
472		-	dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590).
473		-	HEA 1182 — Concur 12
474		-	Amineptine (7-[(10,11-dihydro-5H- dibenzo[a,d]cyclohepten- 5-
475		-	yl)amino] heptanoic acid) (1219).
476		-	Aminorex (1585). Other names: aminoxaphen;
477		-	2-amino-5-phenyl-2-oxazoline; or
478		-	4,5-dihydro-5-phenyl-2-oxazolamine.
479		-	4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-dihydro- 4-methyl-5-(4-
480		-	methylphenyl)- 2- oxazolamine; 4-methyl-5- (4-methylphenyl)-
481		-	4,5-dihydro-1,3-oxazol- 2-amine).
482		-	Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
483		-	-1-one. Synonyms: BMDP, N-benzyl methylone,
484		-	3,4-Methylenedioxy-Nbenzylcathinone,
485		-	N-benzyl-3,4-methylenedioxycathinone.
486		-	Cathinone (1235). Some trade or other names:
487		-	2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
488		-	2-aminopropiophenone; and norephedrone.
489		-	Fenethylline (1503).
490		-	N-Benzylpiperazine (7493). Other names: BZP; and
491		-	1-benzylpiperazine.
492		-	N-ethylamphetamine (1475).
493		-	Mesocarb (N-phenyl-N-(3-(1-
494		-	phenylpropan-2-yl)-1,2,3-oxadiazol-3- ium-5yl)carbamimidate)
495		-	(1227).
496		-	Methcathinone (1237). Some other trade names:
497		-	2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
498		-	Monomethylpropion; UR 1431.
499		-	N, N-dimethylamphetamine (1480). Other names: N,
500		-	N-alpha-trimethyl-benzeneethanamine; and N,
501		-	N-alpha-trimethylphenethylamine.
502		-	Methiopropamine (N-methyl-1- (thiophen-2-yl) propan-2-
503		-	amine) (methiopropamine). (1478).
504		-	(g) Synthetic drugs as defined in IC 35-31.5-2-321.
505		-	SECTION 4. IC 35-48-2-6, AS AMENDED BY P.L.48-2023,
506		-	SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
507		-	JULY 1, 2024]: Sec. 6. (a) The controlled substances listed in this
508		-	section are included in schedule II.
509		-	(b) Any of the following substances, except those narcotic drugs
510		-	listed in other schedules, whether produced directly or indirectly by
511		-	extraction from substances of vegetable origin, or independently by
512		-	means of chemical synthesis, or by combination of extraction and
513		-	chemical synthesis:
514		-	(1) Opium and opiate, and any salt, compound, derivative, or
515		-	preparation of opium or opiate, excluding apomorphine,
516		-	HEA 1182 — Concur 13
517		-	dextrorphan, nalbuphine, naloxone, naltrexone, and their
518		-	respective salts but including:
519		-	(A) raw opium (9600);
520		-	(B) opium extracts (9610);
521		-	(C) opium fluid extracts (9620);
522		-	(D) powdered opium (9639);
523		-	(E) granulated opium (9640);
524		-	(F) tincture of opium (9630);
525		-	(G) codeine (9050);
526		-	(H) dihydroetorphine (9334);
527		-	(I) ethylmorphine (9190);
528		-	(J) etorphine hydrochloride (9059);
529		-	(K) hydrocodone (9193), and any hydrocodone combination
530		-	product, as determined by the federal Food and Drug
531		-	Administration;
532		-	(L) hydromorphone (9150);
533		-	(M) metopon (9260);
534		-	(N) morphine (9300);
535		-	(O) oxycodone (9143);
536		-	(P) oxymorphone (9652);
537		-	(Q) thebaine (9333); and
538		-	(R) oripavine.
539		-	(2) Any salt, compound, isomer, derivative, or preparation thereof
540		-	which is chemically equivalent or identical with any of the
541		-	substances referred to in subdivision (b)(1) of this section, but not
542		-	including the isoquinoline alkaloids of opium.
543		-	(3) Opium poppy and poppy straw.
544		-	(4) Cocaine (9041). Coca leaves (9040) and any salt,
545		-	compound, derivative, or preparation of coca leaves
546		-	(including cocaine (9041) and ecgonine (8180) and their salts,
547		-	isomers, derivatives, and salts of isomers and derivatives), and
548		-	any salt, compound, derivative, or preparation thereof that is
549		-	chemically equivalent or identical with these substances
550		-	except that the substances do not include:
551		-	(A) decocainized coca leaves or an extraction of coca leaves
552		-	that does not contain cocaine or ecgonine;
553		-	(B) [
554		-	123
555		-	I]ioflupane; or
556		-	(C) [
557		-	18
558		-	F]FP-CIT.
559		-	(5) Concentrate of poppy straw (the crude extract of poppy straw
560		-	in either liquid, solid, or powder form which contains the
561		-	phenanthrene alkaloids of the opium poppy) (9670).
562		-	(c) Opiates. Any of the following opiates, including their isomers,
563		-	HEA 1182 — Concur 14
564		-	esters, ethers, salts, and salts of isomers, esters, and ethers whenever
565		-	the existence of these isomers, esters, ethers, and salts is possible
566		-	within the specific chemical designation:
567		-	Alfentanil (9737)
568		-	Alphaprodine (9010)
569		-	Anileridine (9020)
570		-	Bezitramide (9800)
571		-	Bulk dextropropoxyphene (nondosage forms) (9273)
572		-	Carfentanil (9743)
573		-	Dihydrocodeine (9120)
574		-	Diphenoxylate (9170)
575		-	Fentanyl (9801)
576		-	Isomethadone (9226)
577		-	Levo-alphacetylmethadol (9648). Other names:
578		-	Levo-alpha-acetylmethadol; levomethadyl acetate; and LAAM.
579		-	Levomethorphan (9210)
580		-	Levorphanol (9220)
581		-	Metazocine (9240)
582		-	Methadone (9250)
583		-	Methadone-Intermediate, 4-cyano-2-dimethyl-amino-4,
584		-	4-diphenyl butane (9254)
585		-	Moramide-Intermediate, 2-methyl-3-morpholino-1,
586		-	1-diphenylpropane- carboxylic acid (9802)
587		-	Oliceridine (N-[(3-methoxythiophen- 2-yl) methyl]({2- [(9R)-9-
588		-	(pyridin- 2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) (9245)
589		-	Pethidine (Meperidine) (9230)
590		-	Pethidine-Intermediate- A, 4-cyano-1-methyl-4-phenylpiperidine
591		-	(9232)
592		-	Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
593		-	(9233)
594		-	Pethidine-Intermediate-C,1-methyl-4-phenylpiperidine-4-carbo
595		-	xylic acid (9234)
596		-	Phenazocine (9715)
597		-	Piminodine (9730)
598		-	Racemethorphan (9732)
599		-	Racemorphan (9733)
600		-	Remifentanil (9739)
601		-	Sufentanil (9740)
602		-	Tapentadol
603		-	Thiafentanil
604		-	(d) Stimulants. Any material compound, mixture, or preparation
605		-	which contains any quantity of the following substances having a
606		-	HEA 1182 — Concur 15
607		-	potential for abuse associated with a stimulant effect on the central
608		-	nervous system:
609		-	(1) Amphetamine, its salts, optical isomers, and salts of its optical
610		-	isomers (1100).
611		-	(2) Methamphetamine, including its salts, isomers, and salts of its
612		-	isomers (1105).
613		-	(3) Phenmetrazine and its salts (1631).
614		-	(4) Methylphenidate (1724).
615		-	(5) Lisdexamfetamine, its salts, its isomers, and salts of its
616		-	isomers.
617		-	(e) Depressants. Unless specifically excepted by rule of the board
618		-	or unless listed in another schedule, any material, compound, mixture,
619		-	or preparation which contains any quantity of the following substances
620		-	having a depressant effect on the central nervous system, including its
621		-	salts, isomers, and salts of isomers whenever the existence of such
622		-	salts, isomers, and salts of isomers is possible within the specific
623		-	chemical designation:
624		-	Amobarbital (2125)
625		-	Glutethimide (2550)
626		-	Pentobarbital (2270)
627		-	Phencyclidine (7471)
628		-	Secobarbital (2315)
629		-	(f) Immediate precursors. Unless specifically excepted by rule of the
630		-	board or unless listed in another schedule, any material, compound,
631		-	mixture, or preparation which contains any quantity of the following
632		-	substances:
633		-	(1) Immediate precursor to amphetamine and methamphetamine:
634		-	Phenylacetone (8501). Some trade or other names:
635		-	phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl
636		-	ketone.
637		-	(2) Immediate precursors to phencyclidine (PCP):
638		-	(A) 1-phenylcyclohexylamine (7460); or
639		-	(B) 1-piperidinocyclohexanecarbonitrile (PCC) (8603).
640		-	(3) Immediate precursor to fentanyl:
641		-	(A) 4-anilino-N-phenethylpiperidine (ANPP) (8333); or
642		-	(B) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl)
643		-	(8366).
644		-	(g) Hallucinogenic substances:
645		-	Dronabinol oral solution. Other name:
646		-	(-)-delta-9-trans-tetrahydrocannabinol (delta-9-THC).
647		-	Nabilone (7379). Other name: (+/-)-trans-3-
648		-	(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy -6,
649		-	HEA 1182 — Concur 16
650		-	6-dimethyl-9H-dibenzo [b,d] pyran-9-one.
651		-	SECTION 5. IC 35-48-2-10, AS AMENDED BY P.L.48-2023,
652		-	SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
653		-	JULY 1, 2024]: Sec. 10. (a) The controlled substances listed in this
654		-	section are included in schedule IV.
655		-	(b) Narcotic drugs. Unless specifically excepted in a rule adopted
656		-	by the board or unless listed in another schedule, any material,
657		-	compound, mixture, or preparation containing any of the following
658		-	narcotic drugs, or their salts calculated as the free anhydrous base or
659		-	alkaloid, in the following limited quantities:
660		-	(1) Not more than 1 milligram of difenoxin (9618) and not less
661		-	than 25 micrograms of atropine sulfate per dosage unit.
662		-	(2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
663		-	diphenyl-3-methyl-2-propionoxybutane (9278).
664		-	(c) Depressants. Unless specifically excepted in a rule adopted by
665		-	the board or unless listed in another schedule, any material, compound,
666		-	mixture, or preparation which contains any quantity of the following
667		-	substances, including its salts, isomers, and salts of isomers whenever
668		-	the existence of such salts, isomers, and salts of isomers is possible
669		-	within the specific chemical designation:
670		-	Alfaxalone (2731).
671		-	Alprazolam (2882).
672		-	Barbital (2145).
673		-	Brexanolone (2400).
674		-	Bromazepam (2748).
675		-	Camazepam (2749).
676		-	Carisoprodol.
677		-	Chloral betaine (2460).
678		-	Chloral hydrate (2465).
679		-	Chlordiazepoxide (2744).
680		-	Clobazam (2751).
681		-	Clonazepam (2737).
682		-	Clorazepate (2768).
683		-	Clotiazepam (2752).
684		-	Cloxazolam (2753).
685		-	Daridorexant (2410).
686		-	Delorazepam (2754).
687		-	Diazepam (2765).
688		-	Dichloralphenazone (2467).
689		-	Estazolam (2756).
690		-	Ethchlorvynol (2540).
691		-	Ethinamate (2545).
692		-	HEA 1182 — Concur 17
693		-	Ethyl loflazepate (2758).
694		-	Fludiazepam (2759).
695		-	Flunitrazepam (2763).
696		-	Flurazepam (2767).
697		-	Fospropofol (2138).
698		-	Halazepam (2762).
699		-	Haloxazolam (2771).
700		-	Ketazolam (2772).
701		-	Lemborexant (2245).
702		-	Loprazolam (2773).
703		-	Lorazepam (2885).
704		-	Lormetazepam (2774).
705		-	Mebutamate (2800).
706		-	Medazepam (2836).
707		-	Meprobamate (2820).
708		-	Methohexital (2264).
709		-	Methylphenobarbital (mephobarbital) (2250).
710		-	Midazolam (2884).
711		-	Nimetazepam (2837).
712		-	Nitrazepam (2834).
713		-	Nordiazepam (2838).
714		-	Oxazepam (2835).
715		-	Oxazolam (2839).
716		-	Paraldehyde (2585).
717		-	Petrichloral (2591).
718		-	Phenobarbital (2285).
719		-	Pinazepam (2883).
720		-	Prazepam (2764).
721		-	Quazepam (2881).
722		-	Remimazolam (2846).
723		-	Suvorexant (2223).
724		-	Temazepam (2925).
725		-	Tetrazepam (2886).
726		-	Triazolam (2887).
727		-	Zaleplon (2781).
728		-	Zolpidem (Ambien) (2783).
729		-	Zopiclone (2784).
730		-	Zuranolone (2420).
731		-	(d) Fenfluramine. Any material, compound, mixture, or preparation
732		-	which contains any quantity of the following substances, including its
733		-	salts, isomers (whether optical, position, or geometric), and salts of
734		-	such isomers, whenever the existence of such salts, isomers, and salts
735		-	HEA 1182 — Concur 18
736		-	of isomers is possible.
737		-	Fenfluramine (1670).
738		-	(e) (d) Stimulants. Unless specifically excepted in a rule adopted by
739		-	the board or unless listed in another schedule, any material, compound,
740		-	mixture, or preparation which contains any quantity of the following
741		-	substances having a stimulant effect on the central nervous system,
742		-	including its salts, isomers (whether optical, position, or geometric),
743		-	and salts of such isomers whenever the existence of such salts, isomers,
744		-	and salts of isomers is possible within the specific chemical
745		-	designation:
746		-	Cathine ((+)-norpseudoephedrine) (1230).
747		-	Diethylpropion (1610).
748		-	Fencamfamin (1760).
749		-	Fenproporex (1575).
750		-	Mazindol (1605).
751		-	Mefenorex (1580).
752		-	Modafinil (1680).
753		-	Pemoline (including organometallic complexes and chelates
754		-	thereof) (1530).
755		-	Phentermine (1640).
756		-	Pipradrol (1750).
757		-	Serdexmethylphenidate (1729).
758		-	Sibutramine (1675).
759		-	Solriamfetol (2-amino-3-phenylpropyl carbamate;
760		-	benzenepropanol, beta-amino-, carbamate (ester)) (1650).
761		-	SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
762		-	(f) (e) Other substances. Unless specifically excepted or unless
763		-	listed in another schedule, any material, compound, mixture, or
764		-	preparation which contains any quantity of the following substances
765		-	including its salts:
766		-	Butorphanol (including its optical isomers) (9720).
767		-	Pentazocine (9709).
768		-	(g) (f) Tramadol (Ultram).
769		-	(h) (g) The board may except by rule any compound, mixture, or
770		-	preparation containing any depressant substance listed in subsection
771		-	(b), (c), (d), or (e), or (f) from the application of any part of this article
772		-	if the compound, mixture, or preparation contains one (1) or more
773		-	active medicinal ingredients not having a depressant effect on the
774		-	central nervous system, and if the admixtures are included therein in
775		-	combinations, quantity, proportion, or concentration that vitiate the
776		-	potential for abuse of the substances which have a depressant effect on
777		-	the central nervous system.
778		-	HEA 1182 — Concur 19
779		-	SECTION 6. An emergency is declared for this act.
780		-	HEA 1182 — Concur Speaker of the House of Representatives
781		-	President of the Senate
782		-	President Pro Tempore
783		-	Governor of the State of Indiana
784		-	Date: Time:
785		-	HEA 1182 — Concur
	962	+	names: 3–MMC; 3-methylmethcathinone) (1259).".
	963	+	Renumber all SECTIONS consecutively.
	964	+	and when so amended that said bill do pass.
	965	+	(Reference is to HB 1182 as printed January 18, 2024.)
	966	+	FREEMAN, Chairperson
	967	+	Committee Vote: Yeas 8, Nays 0.
	968	+	EH 1182—LS 6758/DI 92 24
	969	+	SENATE MOTION
	970	+	Madam President: I move that Engrossed House Bill 1182 be
	971	+	amended to read as follows:
	972	+	Page 3, delete lines 17 through 42.
	973	+	Delete page 4.
	974	+	Page 5, delete lines 1 through 24.
	975	+	Renumber all SECTIONS consecutively.
	976	+	(Reference is to EHB 1182 as printed February 16, 2024.)
	977	+	GLICK
	978	+	EH 1182—LS 6758/DI 92